Seattle Genetics, Takeda deal

Seattle Genetics disclosed in its 3Q10 earnings that it received an undisclosed milestone payment from Takeda's Millennium Pharmaceuticals Inc. subsidiary under a 2009 deal to use Seattle Genetics' a...